T2 Biosystems Inc Einnahmen
Was ist das Einnahmen von T2 Biosystems Inc?
Einnahmen von T2 Biosystems Inc ist -45.74%
Was ist die Definition von Einnahmen?
Das jährliche Umsatzwachstum der letzten 3 Jahre ist das durchschnittliche Umsatzwachstum der letzten 3 Jahre von einem Jahr zum nächsten.
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
Einnahmen von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu T2 Biosystems Inc
Was macht T2 Biosystems Inc?
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
Unternehmen mit einnahmen ähnlich T2 Biosystems Inc
- China International Development hat Einnahmen von -45.93%
- Twintek Investment hat Einnahmen von -45.87%
- Sinopharm Co hat Einnahmen von -45.85%
- Sinopharm Co hat Einnahmen von -45.85%
- Alector hat Einnahmen von -45.84%
- e Gorgé SA hat Einnahmen von -45.81%
- T2 Biosystems Inc hat Einnahmen von -45.74%
- Dynavax Technologies hat Einnahmen von -45.65%
- Evolution Petroleum hat Einnahmen von -45.64%
- China SXT Pharmaceuticals Inc hat Einnahmen von -45.53%
- Contel Technology hat Einnahmen von -45.53%
- Hazer hat Einnahmen von -45.49%
- 8K Miles Software Services hat Einnahmen von -45.45%